| Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2 … EA Rozeman, AM Menzies, ACJ van Akkooi, C Adhikari, C Bierman, ... The Lancet Oncology 20 (7), 948-960, 2019 | 454 | 2019 |
| Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma EA Rozeman, EP Hoefsmit, ILM Reijers, RPM Saw, JM Versluis, ... Nature medicine 27 (2), 256-263, 2021 | 254 | 2021 |
| Concomitant radio- and fluorescence-guided sentinel lymph node biopsy in squamous cell carcinoma of the oral cavity using ICG-99mTc-nanocolloid NS van den Berg, OR Brouwer, WMC Klop, B Karakullukcu, CL Zuur, ... European journal of nuclear medicine and molecular imaging 39, 1128-1136, 2012 | 188 | 2012 |
| Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial ILM Reijers, AM Menzies, ACJ Van Akkooi, JM Versluis, ... Nature medicine 28 (6), 1178-1188, 2022 | 187 | 2022 |
| Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma JL Vos, JBW Elbers, O Krijgsman, JJH Traets, X Qiao, AM van der Leun, ... Nature communications 12 (1), 7348, 2021 | 154 | 2021 |
| Uncoupling DNA damage from chromatin damage to detoxify doxorubicin X Qiao, SY van der Zanden, DPA Wander, DM Borràs, JY Song, X Li, ... Proceedings of the National Academy of Sciences 117 (26), 15182-15192, 2020 | 136 | 2020 |
| A mechanism of transition from ventricular fibrillation to tachycardia: effect of calcium channel blockade on the dynamics of rotating waves FH Samie, R Mandapati, RA Gray, Y Watanabe, C Zuur, J Beaumont, ... Circulation research 86 (6), 684-691, 2000 | 133 | 2000 |
| Sensorineural hearing loss in patients with head and neck cancer after chemoradiotherapy and radiotherapy: a systematic review of the literature EAR Theunissen, SCJ Bosma, CL Zuur, R Spijker, S van der Baan, ... Head & neck 37 (2), 281-292, 2015 | 106 | 2015 |
| Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: a multivariate analysis CL Zuur, YJ Simis, PE Lansdaal, AA Hart, CR Rasch, JH Schornagel, ... International Journal of Radiation Oncology* Biology* Physics 68 (5), 1320-1325, 2007 | 98 | 2007 |
| Activated neutrophils exert myeloid-derived suppressor cell activity damaging T cells beyond repair CEM Aarts, IH Hiemstra, EP Béguin, AJ Hoogendijk, S Bouchmal, ... Blood advances 3 (22), 3562-3574, 2019 | 95 | 2019 |
| Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer CL Zuur, YJ Simis, PE Lansdaal, AA Hart, JH Schornagel, WA Dreschler, ... Journal of clinical oncology 25 (24), 3759-3765, 2007 | 95 | 2007 |
| The impact of margin reduction on outcome and toxicity in head and neck cancer patients treated with image-guided volumetric modulated arc therapy (VMAT) A Navran, W Heemsbergen, T Janssen, O Hamming-Vrieze, M Jonker, ... Radiotherapy and oncology 130, 25-31, 2019 | 92 | 2019 |
| Total laryngectomy for a dysfunctional larynx after (chemo) radiotherapy EAR Theunissen, AJ Timmermans, CL Zuur, O Hamming-Vrieze, ... Archives of otolaryngology–head & neck surgery 138 (6), 548-555, 2012 | 71 | 2012 |
| Hearing loss due to concurrent daily low-dose cisplatin chemoradiation for locally advanced head and neck cancer CL Zuur, YJW Simis, RS Verkaik, JH Schornagel, AJM Balm, ... Radiotherapy and oncology 89 (1), 38-43, 2008 | 66 | 2008 |
| Prognostic role of tumor infiltrating lymphocytes in EBV positive and EBV negative nasopharyngeal carcinoma ML Ooft, JA van Ipenburg, WW Braunius, CI Zuur, S Koljenović, ... Oral oncology 71, 16-25, 2017 | 61 | 2017 |
| Risk factors for hearing loss in patients treated with intensity-modulated radiotherapy for head-and-neck tumors CL Zuur, YJ Simis, EA Lamers, AA Hart, WA Dreschler, AJ Balm, ... International Journal of Radiation Oncology* Biology* Physics 74 (2), 490-496, 2009 | 58 | 2009 |
| Salvage surgery for advanced stage head and neck squamous cell carcinoma following radiotherapy or chemoradiation JBW Elbers, LI Veldhuis, PA Bhairosing, LE Smeele, K Jóźwiak, ... European Archives of Oto-Rhino-Laryngology 276, 647-655, 2019 | 49 | 2019 |
| Audiometric patterns in ototoxicity of intra-arterial cisplatin chemoradiation in patients with locally advanced head and neck cancer CL Zuur, YJW Simis, PEM Lansdaal, CRN Rasch, RA Tange, AJM Balm, ... Audiology and Neurotology 11 (5), 318-330, 2006 | 47 | 2006 |
| Diagnosis and treatment of isolated neck metastases of adenocarcinomas CL Zuur, MLF Van Velthuysen, JH Schornagel, FJM Hilgers, AJM Balm European Journal of Surgical Oncology (EJSO) 28 (2), 147-152, 2002 | 46 | 2002 |
| Prognostic significance of the EGFR pathway in nasopharyngeal carcinoma: a systematic review and meta-analysis ML Ooft, WW Braunius, P Heus, I Stegeman, PJ Van Diest, W Grolman, ... Biomarkers in medicine 9 (10), 997-1010, 2015 | 45 | 2015 |
